Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA

被引:0
|
作者
Xin-An Lu
Ting He
Zhihai Han
Yanping Ding
Liang Zhao
Guanghua Liu
Floris De Smet
Xiaojun Huang
Danqing Chen
Feifei Qi
Xiangyu Zhao
机构
[1] Peking University People’s Hospital,Department of Pulmonary and Critical Care Medicine
[2] Peking University Institute of Hematology,undefined
[3] National Clinical Research Center for Hematologic Disease,undefined
[4] Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,undefined
[5] Immunochina Pharmaceuticals Co.,undefined
[6] Ltd,undefined
[7] Sartorius Stedim North America Inc.,undefined
[8] The Sixth Medical Center of PLA General Hospital,undefined
来源
Cytotechnology | 2020年 / 72卷
关键词
Supercoiled circular plasmid DNA; Proportion; Lentiviral vector; Titer; Suspension cell culture;
D O I
暂无
中图分类号
学科分类号
摘要
The supercoiled circular (SC) topology form of plasmid DNA has been regarded to be advantageous over open circular or linearized analogue in transfection and expression efficiency, and therefore are largely demanded in the biopharmaceutical manufacturing. However, production of high-purity SC plasmid DNA would result in high manufacturing cost. The effect of SC proportion in plasmid DNA on the quality of packaged lentiviral vectors has never been reported. In this study, we established an efficient system for production of high-titer lentiviral vectors using suspension HEK293SF cells in serum-free media, and the lentiviral titer was not associated with the proportion of SC plasmid DNA. Plasmids DNA with different proportion of SC, open-circular, and linearized forms were prepared using the thermal denaturation method, and were transfected to adherent HEK293T or suspension HEK293SF cells for packaging of lentiviral vectors. The titer of lentiviral vectors from HEK293T cells, but not from HEK293SF cells, was significantly impaired when the proportion of SC plasmid DNA decreased from 60–80% to 30–40%. Further decrease of SC plasmid proportion to 3% led to a dramatic reduction of lentiviral titer no matter the packaging cell line was. However, lentiviral vectors from HEK293SF cells still showed a high titer even when the proportion of SC plasmid DNA was 3%. This study demonstrated that extremely high proportion of SC plasmid DNA was not required for packaging of high-titer lentiviral vector in HEK293SF cells, at least under our manufacturing process.
引用
收藏
页码:897 / 905
页数:8
相关论文
共 50 条
  • [1] Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA
    Lu, Xin-An
    He, Ting
    Han, Zhihai
    Ding, Yanping
    Zhao, Liang
    Liu, Guanghua
    De Smet, Floris
    Huang, Xiaojun
    Chen, Danqing
    Qi, Feifei
    Zhao, Xiangyu
    [J]. CYTOTECHNOLOGY, 2020, 72 (06) : 897 - 905
  • [2] Evaluation of the production of EIAV lentiviral vectors in suspension cells
    Pearson, Laura
    Schiedner, Gudrun
    Wolfel, Jens
    Knevelman, Carol
    Pardo, Hanna
    McCloskey, Laura
    Mitrophanous, Kyriacos
    Stewart, Hannah
    [J]. HUMAN GENE THERAPY, 2014, 25 (05) : A11 - A11
  • [3] Evaluation of the production of EIAV lentiviral vectors in suspension cells
    Pearson, L. J. E.
    Schiedner, G.
    Wolfel, J.
    Knevelman, C.
    Pardo, H.
    McCloskey, L.
    Mitrophanous, K. A.
    Stewart, H. J.
    [J]. HUMAN GENE THERAPY, 2014, 25 (11) : A85 - A85
  • [4] Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media
    Bauler, Matthew
    Roberts, Jessica K.
    Wu, Chang-Chih
    Fan, Baochang
    Ferrara, Francesca
    Yip, Bon Ham
    Diao, Shiyong
    Kim, Young-In
    Moore, Jennifer
    Zhou, Sheng
    Wielgosz, Matthew M.
    Ryu, Byoung
    Throm, Robert E.
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 58 - 68
  • [6] Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors
    H P Lesch
    A Laitinen
    C Peixoto
    T Vicente
    K-E Makkonen
    L Laitinen
    J T Pikkarainen
    H Samaranayake
    P M Alves
    M J T Carrondo
    S Ylä-Herttuala
    K J Airenne
    [J]. Gene Therapy, 2011, 18 : 531 - 538
  • [7] Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors
    Lesch, H. P.
    Laitinen, A.
    Peixoto, C.
    Vicente, T.
    Makkonen, K-E
    Laitinen, L.
    Pikkarainen, J. T.
    Samaranayake, H.
    Alves, P. M.
    Carrondo, M. J. T.
    Yla-Herttuala, S.
    Airenne, K. J.
    [J]. GENE THERAPY, 2011, 18 (06) : 531 - 538
  • [8] Production of supercoiled multimeric plasmid DNA for biopharmaceutical application
    Voss, C
    Schmidt, T
    Schleef, M
    Friehs, K
    Flaschel, E
    [J]. JOURNAL OF BIOTECHNOLOGY, 2003, 105 (03) : 205 - 213
  • [9] Rapid, Consistent and Scalable Production of Viral Vectors in Suspension Cells by Cotransfection of Viral Component Plasmid DNA or RNA
    Brady, James
    Shivakumar, Rama
    Malehorn, Matthew
    Feller, Stephanie
    Allen, Cornell
    Li, Linhong
    Chopas, Nicholas
    Dzekunov, Sergey
    Peshwa, Madhusudan V.
    Liu, Linda N.
    [J]. MOLECULAR THERAPY, 2006, 13 : S317 - S317
  • [10] Production of lentiviral vectors using novel, enzymatically produced, linear DNA
    Rajvinder Karda
    John R. Counsell
    Kinga Karbowniczek
    Lisa J. Caproni
    John P. Tite
    Simon N. Waddington
    [J]. Gene Therapy, 2019, 26 : 86 - 92